✦ LIBER ✦

Implementing changes in clinical practice to improve the management of Crohn's disease

✍ Scribed by Remo Panaccione; Toshifumi Hibi; Laurent Peyrin-Biroulet; Stefan Schreiber

Book ID: 119636972
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 213 KB
Volume: 6
Category: Article
ISSN: 1873-9946
DOI: 10.1016/s1873-9946(12)60503-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to letter to the Editor – Imple

Response to letter to the Editor – Implementation of integrative approaches to improve the design of Crohn's disease clinical trials

✍ Bassaganya-Riera, Josep; Hontecillas, Raquel; Isaacs, Kim L. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Current practice in management of Crohn'

Current practice in management of Crohn's disease in Wales

✍ P.K. Rao Dhruva; P.E. Price; J. Torkington 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 442 KB

Practice Parameters for the Surgical Man

Practice Parameters for the Surgical Management of Crohn’s Disease

✍ Scott A. Strong; Walter A. Koltun; Neil H. Hyman; W. Donald Buie; the Standards 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 262 KB

25 OP Change in the clinical behaviour o

25 OP Change in the clinical behaviour of Crohn's disease

✍ G. Antonelli; C. Papi; C. Fagnani; L. Gili; M. Koch; L. Capurso 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Natalizumab for moderate to severe Crohn

Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience

✍ S.V. Kane; S. Horst; W.J. Sandborn; B. Becker; B. Neis; M. Moscandrew; K.A. Hans 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Adalimumab for Crohn's disease in clinic

Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients

✍ Jason M. Swoger; Edward V. Loftus Jr.; William J. Tremaine; William A. Faubion; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Background: We sought to assess the effectiveness and safety of adalimumab for the treatment of Crohn's disease (CD) in clinical practice. Methods: Demographic, clinical, and treatment data were abstracted from the medical record. The primary outcome was clinical response to induction therapy